American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316.
2.
Neonatal Jaundice. 2010. NICE website. https://www.nice.org.uk/guidance/cg98/evidence/full-guideline-245411821. Accessed August 25, 2019.
3.
NarangA, GathwalaG, KumarP.Neonatal jaundice: an analysis of 551 cases. Indian Pediatr. 1997;34:429–432.
4.
OlusanyaBO, OgunlesiTA, SlusherTM.Why is kernicterus still a major cause of death and disability in low and middle-income countries? Arch Dis Child. 2014;99:1117–1121.
5.
BhutaniVK, JohnsonLH.Managing the assessment of neonatal jaundice: importance of timing. Indian J Pediatr. 2000;67(10):733–737.
6.
GuruprasadG, ChawlaD, AggarwalS, NarangA, DeorariAK.Management of neonatal hyperbilirubinemia. In: KumarP, JainN, ThakreR, MurkiS, VenkataseshanS, eds. Evidence Based Clinical Practice Guidelines. India: National Neonatology Forum; 2010:139–153.
7.
The Canadian Paediatric Society. Hyperbilirubinemia in term newborn infants. Can Fam Physician. 1999;45:2690–2692, 2695, 2713–2716.
8.
BhutaniVK, MaiselsMJ, StarkAR, Expert Committee for Severe Neonatal Hyperbilirubinemia, European Society for Pediatric Research, et al. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or=35 weeks gestation. Neonatology. 2008;94(1):63–67.
9.
NICE. Jaundice in newborn babies under 28 days. NICE [Internet]. [cited September 26, 2019]. https://www.nice.org.uk/guidance/cg98/resources. Accessed November 25, 2020.
10.
BratlidD, NakstadB, HansenTWR.National guidelines for treatment of jaundice in the newborn. Acta Paediatr. 2011;100(4):499–505.
11.
FlahermanVJ, MaiselsMJ, Academy of Breastfeeding Medicine. ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation—Revised 2017. Breastfeed Med Off J Acad Breastfeed Med. 2017;12(5):250–257.
12.
MaiselsMJ, WatchkoJF, BhutaniVK, StevensonDK.An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012;32(9):660–664.
13.
HassanShabuj M, HossainJ, DeyS.Accuracy of transcutaneous bilirubinometry in the preterm infants: a comprehensive meta-analysis. J Matern Fetal Neonatal Med. 2019;32(5):734–741.
14.
NagarG, VandermeerB, CampbellS, KumarM.Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics. 2013;132(5):871–881.
15.
Van den Esker-JonkerB, denBoer L, PeppingRM, BekhofJ.Transcutaneous bilirubinometry in jaundiced neonates: a randomized controlled trial. Pediatrics. 2016;138(6):e20162414.
16.
MishraS, ChawlaD, AgarwalR, DeorariAK, PaulVK, BhutaniVK.Transcutaneous bilirubinometry reduces the need for blood sampling in neonates with visible jaundice. Acta Paediatr. 2009;98(12):1916–1919.
17.
WainerS, ParmarSM, AllegroD, et al. Impact of a transcutaneous bilirubinometry program on resource utilization and severe hyperbilirubinemia. Pediatrics. 2012;129:77–86.
18.
TaylorJA, BurgosAE, FlahermanVet al; BORN Investigators. Utility of decision rules for transcutaneous bilirubin measurements. Pediatrics. 2016;137(5):e20153032.
19.
McCleanS, BaergK, Smith-FehrJ, SzafronM.Cost savings with transcutaneous screening versus total serum bilirubin measurement for newborn jaundice in hospital and community settings: a cost-minimization analysis. CMAJ Open. 2018;6(3):E285–E291.
20.
MaiselsMJ, CluneS, ColemanK, et al. The natural history of jaundice in predominantly breastfed infants. Pediatrics. 2014;134(2):e340–e345.
21.
GartnerLM.Breastfeeding and jaundice. J Perinatol Off J Calif Perinat Assoc. 2001;21(Suppl 1):S25-29; S35-S39.
22.
PreerGL, PhilippBL.Understanding and managing breast milk jaundice. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):F461-F466.
23.
SoldiA, TonettoP, VaraldaA, BertinoE.Neonatal jaundice and human milk. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2011;24(Suppl 1):85–87.
24.
BrattonS, SternM.Breast milk jaundice. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 [cited September 26, 2019]. http://www.ncbi.nlm.nih.gov/books/NBK537334/. Accessed November 25, 2020.
25.
TiwariS, BharadvaK, YadavB, etal.Infant and young Child feeding guidelines, 2016. Indian Pediatr. 2016;53(8):703–713.
26.
YaseenH, KhalafM, RashidN, DarwichM.Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs’ test? J Perinatol. 2005;25(9):590.
27.
NuntnarumitP, NakaC.Comparison of the effectiveness between the adapted-double phototherapy versus conventional single phototherapy. J Med Assoc Thai. 2002;85(Suppl. 4):S1159-S1166.
28.
BoonyarittipongP, KriangburapaW, BooranavanichK.Effectiveness of double-surface intensive phototherapy versus single surface intensive phototherapy for neonatal hyperbilirubinemia. J Med Assoc Thai. 2008;91:(1)50–55.
29.
HamidIJ, IyenMI, IbrahimNRet al. Randomised controlled trial of single phototherapy with reflecting curtains versus double phototherapy in term newborns with hyperbilirubinaemia. J Paediatr Child Health. 2013;49:375–379.
30.
DonneborgM, VandborgPK, HansenBM, Rodrigo-DomingoM, EbbesenF.Double versus single intensive phototherapy with LEDs in treatment of neonatal hyperbilirubinemia. J Perinatol. 2018;38(2):154–158.
31.
NaderiS, SafdarianF, MazloomiD, et al.Efficacy of double and triple phototherapy in term newborns with hyperbilirubinemia: the first clinical trial. Pediatr Neonatol. 2009;50:266–269.
32.
HoltropPC, RuedisueliK, MaiselsMJ.Double versus single phototherapy in low birth weight newborns. Pediatrics. 1992;90(5):674–677.
33.
Al-MasriH.In healthy baby with severe jaundice do we need to give fluid supplementation during phototherapy? Sudan Med J. 2012;48(3):176–180.
34.
BooNY, LeeHT.Randomized controlled trial of oral versus intravenous fluid supplementation on serum bilirubin level during phototherapy of term infants with severe hyperbilirubinaemia. J Paediatr Child Health. 2002;38(2):151–155.
35.
EasaZO. Effect of intravenous fluid supplementation on serum bilirubin level during conventional phototherapy of term infants with severe hyperbilirubinemia. Al-Qadisiah Med J. 2013;9(15):36–45.
36.
IranpourR, NohekhanR, HaghshenasI.Effect of intravenous fluid supplementation on serum bilirubin level in jaundiced healthy neonates during conventional phototherapy. J Res Med Sci. 2004;9(4):186–190.
37.
MehtaS, KumarP, NarangA.A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr. 2005;147(6):781–785.
38.
PatelM, MunshiS, MehariyaKM.Effect of fluid supplementation in severe neonatal hyperbilirubinemia. Int J Sci Res. 2014;3(12):2524–2526.
39.
SaeidiR, HeydarianF, FakehiV.Role of intravenous extra fluid therapy in icteric neonates receiving phototherapy. Saudi Med J. 2009;30(9):1176–1179.
40.
GoyalP, MehtaA, KaurJ, JainS, GuglaniV, ChawlaD.Fluid supplementation in management of neonatal hyperbilirubinemia: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018;31(20):2678–2684.
41.
YamauchiY, KasaN, YamanouchiI.Is it necessary to change the babies’ position during phototherapy? Early Hum Dev. 1989;20(3-4):221-227.
42.
ChenCM, LiuSH, LaiCC, HwangCC, HsuHH. Changing position does not improve the efficacy of conventional phototherapy. Acta Paediatr Taiwan. 2002;43(5):255-258.
43.
DonneborgML, KnudsenKB, EbbesenF.Effect of infants’ position on serum bilirubin level during conventional phototherapy. Acta Paediatr. 2010;99(8):1131-1134.
44.
MohammadzadehA, BostaniZ, JafarnejadF, MazloomR.Supine versus turning position on bilirubin level during phototherapy in healthy term jaundiced neonates. Saudi Med J.2004;25(12):2051-2052.
45.
ShinwellES, SciakyY, KarplusM.Effect of position change on bilirubin levels during phototherapy. J Perinatol. 2002;22(3):226-229.
46.
BhethanabhotlaS, ThukralA, SankarMJ, AgarwalR, PaulVK, DeorariAK.Effect of position of infant during phototherapy in management of hyperbilirubinemia in late preterm and term neonates: a randomized controlled trial. J Perinatol. 2013;33(10):795-799.
47.
KaplanM, MerlobP, RegevR.Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol. 2008;28(6):389–397.
48.
Sánchez-RedondoSánchez-Gabriel MD, LeanteCastellanos JL, BenaventeFernández I, et al.Guidelines for prevention, detection and management of hyperbilirubinaemia in newborns of 35 or more weeks of gestation. An Pediatr (Barc). 2017;87:294.e1-294.e8.
49.
NagarG, VandermeerB, CampbellS, KumarM.Effect of phototherapy on the reliability of transcutaneous bilirubin devices in term and near term infants: a systematic review and meta-analysis. Neonatology. 2016;109:209–212.
50.
NagarG, KumarM.Effect of phototherapy on the diagnostic accuracy of transcutaneous bilirubin in preterm infants. J Clin Neonatol. 2017;6:148–153.
51.
LucanovaL, MatasovaK, ZibolenM, KirchoP.Accuracy of transcutaneous bilirubin measurement in newborns after phototherapy. J Perinatol. 2016;36:858–861.
52.
HulzebosCV, Vader-vanImhoff DE, BosAF, DijkPH.Should transcutaneous bilirubin be measured in preterm infants receiving phototherapy? The relationship between transcutaneous and total serum bilirubin in preterm infants with and without phototherapy. PLoS One. 14(6):e0218131.
53.
CheungKHS, TanMG, Fook-ChongSMC, YeoCL.Agreement between transcutaneous bilirubin and serum bilirubin measurements before, during and after phototherapy in term and preterm neonates a prospective cohort study in an Asian multi-ethnic population. Ann Pediatr Res. 2019;3(1):1018.
54.
CucuyM, Juster-ReicherA, FlidelO, ShinwellE.Correlation between transcutaneous and serum bilirubin in preterm infants before, during, and after phototherapy. J Matern Fetal Neonatal Med. 2018;31(10):1323–1326.
55.
TaylorJA, BurgosA, FlahermanV, et al. Discrepancies between transcutaneous and serum bilirubin measurements. Pediatrics. 2015;135(2):224–231.
56.
ZwiersC, Scheffer-RathME, LoprioreE, HaasM de, LileyHG.Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database Syst Rev [Internet]. 2018 [cited September 18, 2019];(3). https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003313.pub2/full. Accessed November 25, 2020.
57.
DashN, KumarP, SundaramV, AttriSV.Preexchange albumin administration in neonates with hyperbilirubinemia: a randomized controlled trial. Indian Pediatr. 2015;52(9):763–767.
58.
MitraS, SamantaM, SarkarM, DeAK, ChatterjeeS.Pre-exchange albumin infusion in low birth weight neonates with intensive phototherapy failure–a randomized controlled trial. J Trop Pediatr. 2011;57(3):217–221.
59.
ShahianM, MoslehiMA.Effect of albumin administration prior to exchange transfusion in term neonates with hyperbilirubinemia–a randomized controlled trial. Indian Pediatr. 2010;47(3):241–244.
60.
ChanG, SchiffD.Variance in albumin loading in exchange transfusions. J Pediatr. 1976;88(4 Pt 1):609–613.
